This page requires you to enable JavaScript in your web browser for complete functionality.
Healthwise

Encephalitis, Herpes Simplex


National Organization for Rare Disorders, Inc.

Synonyms

  • Herpes Encephalitis
  • HSE
  • Herpetic Brainstem Encephalitis
  • Herpetic Meningoencephalitis

Disorder Subdivisions

  • None

Related Disorders List

Information on the following diseases can be found in the Related Disorders section of this report:

  • Encephalitis
  • Meningitis
  • Neurosyphilis

General Discussion

Herpes simplex encephalitis (HSE) is a rare neurological disorder characterized by inflammation of the brain (encephalitis). Common symptoms include headaches, fevers, drowsiness, hyperactivity, and/or general weakness. The disorder may have some symptoms similar to those associated with meningitis, such as a stiff neck, altered reflexes, confusion, and/or speech abnormalities. Skin lesions usually are not found in association with herpes simplex encephalitis. Herpes simplex encephalitis is caused by a virus known as herpes simplex virus (HSV).
.

Symptoms

Symptoms associated with herpes simplex encephalitis usually develop over several days, often without warning. Early symptoms include headaches, fevers, and seizures. Additional symptoms include drowsiness with general weakness (stupor), and confusion or disorientation.

After the initial symptoms appear, affected individuals may develop speech abnormalities such as a diminished ability to communicate by speech, writing, and/or signs (aphasia), absence of the sense of smell (anosmia), and memory loss. In some cases, behavioral changes such as hyperactivity or psychotic episodes occur. Some symptoms of herpes simplex encephalitis may mimic meningitis. These symptoms may include a stiff neck, altered reflexes, confusion, convulsions, and paralysis.

Individuals with herpes simplex encephalitis may develop more severe symptoms, including loss of consciousness, hallucinations, and partial paralysis (hemiparesis). In some rare cases, herpes simplex encephalitis may affect the nerve-rich membrane lining the eyes (retina), resulting in inflammation of the retina (retinitis).
.

Causes

Herpes simplex encephalitis is a complication of infection with the herpes simplex virus. In most cases, the disorder results from herpes simplex virus type I (HSV-I). In rare cases, usually in newborns (neonatals), the disorder is caused by herpes simplex virus type II (HSV-II).

Herpes simplex infection is an acute viral disease usually spread from person to person. It is marked by small fluid-filled blisters appearing on the lips or genitals often accompanied by fever. Herpes simplex encephalitis rarely occurs in conjunction with oral or genital lesions. The herpes virus may become immediately active or remain in the body in an inactive (dormant or latent) state. After being active, the virus may become inactive and then recur (reactivate).

Symptoms associated with herpes simplex encephalitis may occur due to tissue degeneration associated with bleeding (hemorrhagic necrosis) of a tongue-shaped lobe (i.e., temporal lobe) of the cerebral hemisphere.

Affected Populations

Herpes simplex encephalitis usually occurs during early childhood or adulthood. It affects males and females in equal numbers. The disorder is the most common form of acute encephalitis in the United States with approximately 2,000 cases occurring per year. It accounts for 10 percent of all cases of encephalitis in the United States per year.
.

Related Disorders

Symptoms of the following disorders can be similar to those of herpes simplex encephalitis. Comparisons may be useful for a differential diagnosis:

Encephalitis is an inflammation of the brain. There are several different types of encephalitis that differ in cause, parts of the body affected, severity, and areas of the world where they occur. The symptoms of these disorders may also overlap with or resemble other infectious disorders. Symptoms common to all forms of encephalitis include fever, fatigue, drowsiness, and confusion. Causes of encephalitis include herpes simplex virus, varicella zoster virus, arboviruses, and enteroviruses. Encephalitis may also occur secondary to other disorders.

Meningitis is a disorder characterized by inflammation of the membranes surrounding the brain and spinal cord. There are many types of meningitis, caused by many different infectious agents. The infection can range from mild to severe. Meningitis may also accompany other infections such as herpes simplex encephalitis. Symptoms may include fever, headaches, nausea, vomiting, and stiff neck. (For more information on this disorder, choose "meningitis" as your search term in the Rare Disease Database.)

Neurosyphilis occurs when the syphilis bacterium spreads to the central nervous system. Syphilis is a chronic infectious disease caused by a bacterium (microorganism) (treponema pallidum). Affected individuals may not develop any associated symptoms. In some cases, individuals will experience seizures, headaches, fevers, stiff neck, dementia, and behavioral abnormalities. (For more information, choose "syphilis" as your search term in the Rare Disease Database).
.

Standard Therapies

Diagnosis
A diagnosis of idiopathic herpes simplex encephalitis is made based upon a detailed patient history, a thorough clinical evaluation, identification of classic symptoms, and a variety of specialized tests. These tests include polymerase chain reaction (PCR) in cerebrospinal fluid (CSF), which may confirm infection of CSF with the herpes simplex virus. In some cases, advanced imaging techniques such as computed tomography and magnetic resonance imaging (MRI) can also be beneficial in diagnosing a case of herpes simplex encephalitis.

Treatment
Prompt treatment of individuals with herpes simplex encephalitis is important as it improves the efficiency of treatment options.

Treatment with the antiviral drug Zovirax (acyclovir) has resulted in a dramatic improvement of symptoms in most individuals with herpes simplex encephalitis. It is manufactured by GlaxoSmithKline.

Another antiviral drug that has been used to treat herpes simplex encephalitis is vidarabine. However, antiviral therapy may not benefit affected individuals in advanced stages of the infection. Antiviral therapy should be started as soon as herpes simplex encephalitis is suspected.

Seizures that are often associated with herpes simplex encephalitis may be treated with drugs that reduce, prevent, or suppress seizures (anticonvulsants).
.

Investigational Therapies

Information on current clinical trials is posted on the Internet at www.clinicaltrials.gov. All studies receiving U.S. government funding, and some supported by private industry, are posted on this government web site.

For information about clinical trials being conducted at the NIH Clinical Center in Bethesda, MD, contact the NIH Patient Recruitment Office:

Tollfree: (800) 411-1222
TTY: (866) 411-1010
Email: prpl@cc.nih.gov

For information about clinical trials sponsored by private sources, contact:
www.centerwatch.com

References

McJunkin JE, et al. La crosse encephalitis in children. N Engl J Med. 2001;11:801-807.

Maertzdorf J, et al. Herpes simplex virus type 1 (HSV-1)—induced retinitis following herpes simplex encephalitis: indications for brain-to-eye transmission of HSV-1. Ann Neurol. 2000;48:936-39.

Sauerbrei A, et al. Virological diagnosis of herpes simplex encephalitis. J Clin Virol. 2000;17:31-36.

Garcia de Tena J, et al. The value of polymerase chain reaction in cerebrospinal fluid for the diagnosis of herpetic encephalitis: a report of 2 cases and a review of the literature. An Med Interna. 2000;17:81-83.

Chan PK, et al. Use of oral valaciclovir in a 12-year-old boy with herpes simplex encephalitis. Hong Kong Med J. 2000;6:119-21.

Garcia-Barragan N, et al. An unusual presentation of herpetic encephalitis. Rev Neurol. 2000;30:441-44.

Pavone P, et al. Early relapse of herpes simplex encephalitis. Clinical and therapeutic implications. Minerva Pediatr. 1999;51:395-98.

Ito Y, et al. Exacerbation of herpes simplex encephalitis after successful treatment with acyclovir. Clin Infect Dis. 1999;30:185-87.

Kaplan CP, et al. Cognitive outcome after emergent treatment of acute herpes simplex encephalitis with acyclovir. Brain Inj. 1999;13:935-41.

Levitz RE. Herpes simplex encephalitis: a review. Heart Lung. 1998;27:209-12.

McGrath N, et al. Herpes simplex encephalitis treated with acyclovir: diagnosis and long term outcome. J Neurol Neurosug Psychiatry. 1997;63:321-26.

Hokkanen L, et al. Cognitive recovery instead of decline after acute encephalitis: a prospective follow up study. J Neurol Neurosurg Psychiatry. 1997;63:222-27.

Paillard C, et al. Recurrence of herpes simplex encephalitis. Arch Pediatr. 1999;6:1081-85.

Foucher A, et al. Herpetic encephalitis: prognostic elements in adults and children (49 cases). Rev Electroencephalogr Neurophysiol Clin. 1985;15:185-93.

Taylor WB, et al. Ocular infection with herpes simplex virus type 1: prevention of acute herpetic encephalitis by systemic administration of virus-specific antibody. J Infect Dis. 1979;140:534-40.

Resources

Transverse Myelitis Association
1787 Sutter Parkway
Powell, OH 43065-8806
USA
Tel: (614)766-1806
Email: ssiegel@myelitis.org
Internet: http://www.myelitis.org

Centers for Disease Control and Prevention
1600 Clifton Road NE
Atlanta, GA 30333
Tel: (404)639-3534
Tel: (800)311-3435
Email: http://www.cdc.gov/netinfo.htm
Internet: http://www.cdc.gov/

NIH/National Institute of Allergy and Infectious Diseases
6610 Rockledge Drive
MSC 6612
Bethesda, MD 20892-6612
Tel: (301)496-5717
Fax: (301)402-3573
TDD: (800)877-8339
Internet: http://www.niaid.nih.gov/

National Institute of Neurological Disorders and Stroke (NINDS)
31 Center Drive
8A07
Bethesda, MD 20892-2540
Tel: (301)496-5751
Fax: (301)402-2186
Tel: (800)352-9424
Email: braininfo@ninds.nih.gov
Internet: http://www.ninds.nih.gov/

Encephalitis Global
1638 Pierard Road
North Vancouver
British Columbia, Intl V7J 1Y2
Canada
Tel: 604-980-2236
Fax: 6049040809
Email: admin@encephalitisglobal.org
Internet: http://www.encephalitisglobal.org

MUMS (Mothers United for Moral Support, Inc) National Parent-to-Parent Network
150 Custer Court
Green Bay, WI 54301-1243
USA
Tel: (920)336-5333
Fax: (920)339-0995
Tel: (877)336-5333
Email: mums@netnet.net
Internet: http://www.netnet.net/mums/

Encephalitis Society
7B Saville Street
Malton, North Yorkshire, YO17 7LL
UK
Tel: 44 (0) 1652 625 583
Email: mail@encephalitis.info
Internet: http://www.encephalitis.info

Genetic and Rare Diseases (GARD) Information Center
PO Box 8126
Gaithersburg, MD 20898-8126
Tel: (301)519-3194
Fax: (240)632-9164
Tel: (888)205-2311
TDD: (888)205-3223
Email: gardinfo@nih.gov
Internet: http://www.genome.gov/10000409

For a Complete Report

This is an abstract of a report from the National Organization for Rare Disorders, Inc.® (NORD). CIGNA members can access the complete report by logging into myCIGNA.com. For non-CIGNA members, a copy of the complete report can be obtained for a small fee by visiting the NORD website. The complete report contains additional information including symptoms, causes, affected population, related disorders, standard and investigational treatments (if available), and references from medical literature. For a full-text version of this topic, see http://www.rarediseases.org/search/rdblist.html.

The information provided in this report is not intended for diagnostic purposes. It is provided for informational purposes only. NORD recommends that affected individuals seek the advice or counsel of their own personal physicians.

It is possible that the title of this topic is not the name you selected. Please check the Synonyms listing to find the alternate name(s) and Disorder Subdivision(s) covered by this report

This disease entry is based upon medical information available through the date at the end of the topic. Since NORD's resources are limited, it is not possible to keep every entry in the Rare Disease Database completely current and accurate. Please check with the agencies listed in the Resources section for the most current information about this disorder.

For additional information and assistance about rare disorders, please contact the National Organization for Rare Disorders at P.O. Box 1968, Danbury, CT 06813-1968; phone (203) 744-0100; web site www.rarediseases.org or email orphan@rarediseases.org

Last Updated:  5/15/2009
Copyright  1987, 1989, 1990, 1991, 2001, 2009 National Organization for Rare Disorders, Inc.



This information does not replace the advice of a doctor. Healthwise disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.